Small Cell Lung Cancer
The TROPiCS-03 trial, a multicohort, open-label basket study, is assessing the antibody-drug conjugate in solid tumors.
Lauren Averett Byers, MD, will be honored with the award during the TAMEST Annual Conference in February.
The foundation's 2024 Scientific Grant Program awards mark the "largest single-year investment in its history.”
A new study illustrated the importance of exercise for patients with lung cancer who experience cancer-related fatigue.
The Breakthrough Therapy Designation is based on results from the ES-SCLC cohort in the global phase 2 TROPiCS-03 study.
The phase 2 expansion portion of the trial will enroll approximately 50 patients at 10 to 15 sites in the United States.
Advertisement
Expert Interviews on Lung Cancer
Advertisement
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.